TABLE 2.

Baseline characteristics of AYA survivors

Predictor	Category	N	% of Cohort
Total		1574	100
Sex	Male	982	62.4
	Female	592	37.6
Age at diagnosis	15–15.9	215	13.6
	16–16.9	252	16
	17–17.9	287	18.2
	18–18.9	289	18.3
	19–19.9	250	15.8
	20–20.9	281	17.8
Primary diagnosis	Hodgkin lymphoma	641	40.7
	Non‐Hodgkin lymphoma	191	12.1
	Leukemia‐AML +Other	83	5.3
	Leukemia ‐ALL	151	9.6
	Soft‐tissue sarcoma	124	7.9
	Bone sarcoma	119	7.6
	Testicular cancer	265	16.8
Treatment location of first cancer	Pediatric cancer center	508	32.3
	Adult cancer center	886	56.3
	Community hospital	180	11.4
Chemotherapy	Yes	1197	76.1
	No	377	23.9
Radiation	Head + Brain	118	7.5
	Neck	431	27.4
	Thorax	488	31
	Abdomen + Pelvis	214	13.6
	Other	198	12.6
	No	920	58.4
Hematopoietic stem‐cell transplant prior to index	Autologous	69	4.3
	Allogeneic	68	4.3
	No	1439	91.4
SMN prior to index b	Yes	10	0.6
	No	1564	99.4
Relapse/progression prior to index	Yes	175	11.1
	No	1399	88.9
Socioeconomic status (SES) a	1 low deprivation	272	17.3
	2	297	18.9
	3	320	20.3
	4	338	21.5
	5 high deprivation	335	21.3
	Unknown	12	0.8
Rurality a	Yes	167	10.6
	No	1403	89.4

^a Covariate was updated over time but presented in the table at baseline only.

^b SMN = Second malignant neoplasms.